Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 

[search the news]  
 

Health and Pharmaceutical News Archive

 
                                                                   

 
Search our news archive and pharma companies…

Today's News | Note: News feeds may no longer be available for the articles on this page.

BioMarin Acquires Huxley Pharmaceuticals, Inc. 4:31 PM 10/26/2009
Reuters
BioMarin Pharmaceutical Inc has acquired Huxley Pharmaceuticals Inc with technology aimed at treating the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). ...

FDA: Human Genome anthrax drug data raises issues 12:03 PM 10/26/2009
Reuters
US FDA inspections identified issues that raise important concerns about the quality and reliability of human pharmacokinetic data in Human Genome Sciences Inc's application for ABthrax (raxibacumab). ...

SuperGen signs cancer-drug deal with Glaxo 10:20 AM 10/26/2009
Reuters
Cancer drug developer SuperGen Inc entered into a multi-year collaboration with GlaxoSmithKline to discover and develop cancer therapeutics for an upfront payment of $5 million. Total potential development and commercialization milestones payable could exceed $375 million. ...

Obama Declares Swine Flu a National Emergency 12:41 PM 10/24/2009
Bloomberg
President Obama declared swine flu a national emergency in a proclamation designed to help US medical treatment facilities deal with a surge in H1N1 influenza patients by waiving certain government rules. ...

Proximagen plans to buy Cambridge Biotechnology 6:48 AM 10/24/2009
Reuters
Proximagen plans to buy Cambridge Biotechnology from Sweden's Biovitrum marking the first stage of its acquisition strategy focused on central nervous system treatment. ...

FDA approves emergency use of new intravenous flu drug, peramivir 3:41 AM 10/24/2009
The Canadian Press
The US FDA granted emergency use approval for peramivir at the request of the Centers for Disease Control. The drug is manufactured by BioCryst Pharmaceuticals. ...

Human Genome anthrax drug said to work in animals 12:03 PM 10/23/2009
Reuters
Human Genome Sciences Inc drug ABthrax (raxibacumab) worked in animals exposed to anthrax. ...

 

 

Federal panel does not recommend Gardasil in boys... now what? 7:26 AM 10/23/2009
Baltimore Sun
CDC advisory panel does not recommend the HPV-vaccine Gardasil be used routinely in males. It was hoped that it would cut down on the sexually transmitted HPV that can cause cervical cancer. ...

Diabetes drug 'trumps fat pill' 5:01 AM 10/23/2009
BBC News
Patients receiving liraglutide which contains a satiety hormone were twice as likely to lose weight as those on orlistat. It curbs hunger and reduces risk factors for diabetes. ...

Flu Vaccine Requirement for Health Workers Is Lifted 3:31 AM 10/23/2009
New York Times
The Centers for Disease Control and Prevention and World Health Organization didn't recommend mandatory H1N1 vaccinations. New York's insistence on mandatory vaccinations stood alone as no other state adopted a similar regulation. ...

Novartis CEO Says Most US Swine Flu Vaccine Coming Next Year 2:00 PM 10/22/2009
Bloomberg
Most of Novartis’ swine flu vaccine may not reach the US until the first quarter of 2010 due to the initial lack of seed antigen from the CDC. ...

Peregrine drug prompts response in cancer study 2:47 PM 10/21/2009
The Associated Press
Peregrine Pharmaceuticals Inc's drug candidate bavituximab in combination with Sanofi-Aventis' chemotherapy drug Taxotere showed improved response rates in advanced breast cancer patients during a midstage clinical trial. ...

FDA declines to approve King's heart imaging drug 7:27 AM 10/21/2009
Reuters
The US FDA declined to approve King Pharmaceuticals Inc's heart imaging agent CorVue injection. ...

Antigenics to get negative EU opinion on cancer vaccine 5:33 AM 10/21/2009
Reuters
Antigenics Inc was informed by the European health regulator that the company would get a negative opinion on the marketing application of its experimental cancer vaccine Oncophage. ...

Sanofi buys Wellstat drug for up to $350 mln 5:05 AM 10/21/2009
Reuters
Sanofi-Aventis agreed to pay Wellstat Therapeutics up to $350 million for its oral "insulin sensitiser" drug PN2034 to treat Type II diabetes currently undergoing Phase II mid-stage clinicals. ...

<- Day Earlier | Today's News


 

FindingHealthOnline | Drug Thesaurus | Brand Names | Generic Names | News Digests | For Industry

You may search any of the key words from this page using the search window at the top.

© 2012 Betterchem.com